BLOGS

Are We Ready for Serologic Testing During the SARS-CoV-2 Pandemic?

Published by Irving Nachamkin, DrPH, MPH, D(ABMM), FAAM, FIDSA, on April 08, 2020

It was inevitable that companies would start pushing out tests for measuring antibodies to SARS-CoV-2, but there has been a lot of discussion in our professional circles about the status of these assays and whether there is value to use them in the current situation.

Read more

Zika Virus Testing and the Continuing Saga of FDA Oversight of Lab-Developed Tests

Published by Irving Nachamkin, DrPH, MPH, D(ABMM), FAAM, FIDSA, on May 09, 2016

The Zika outbreak provides a good example of why the FDA’s position on LDTs is misguided.

Read more

Laboratory Developed Tests (LDTs)

Published by Irving Nachamkin, DrPH, MPH, D(ABMM), FAAM, FIDSA, on December 22, 2015

We need congressional action to modernize CLIA regulations that ensure the quality of Lab Developed Tests (LDTs), rather than having the FDA impose new and unrealistic regulations on top of CLIA requirements.

Read more

How Many Lab Tests Do Patients Really Need?

Published by Irving Nachamkin, DrPH, MPH, D(ABMM), FAAM, FIDSA, on September 29, 2015

Reducing unnecessary lab tests needs to be part of the routine thought process for every patient by every provider of care.

Read more

Why We Celebrate Lab Week

Published by Irving Nachamkin, DrPH, MPH, D(ABMM), FAAM, FIDSA, on April 17, 2015

April is an exciting time of year for all who work in Pathology and Laboratory Medicine. We get to enjoy longer daylight, warmer temperatures, but, especially, we celebrate our own during Medical Laboratory Professionals Week, aka Lab Week.

Read more

When You Say “The Lab”—Who Are We, Really?

Published by Irving Nachamkin, DrPH, MPH, on January 15, 2015

On a recent morning, I asked a few non-lab staff whether they knew what goes on in “The Lab” and even where “The Lab” was located. Many of the physician providers I have come to know over the years don’t even know the answer.

Read more